441 Visualizing influenza virus infection in living mice.
http://www.nature.com/ncomms/2013/130911/ncomms3369/full/ncomms3369.html
440 Cholera Toxin Disrupts Barrier Function by Inhibiting Exocyst-Mediated Trafficking of Host Proteins to Intestinal Cell Junctions.
http://www.cell.com/cell-host-microbe/abstract/S1931-3128(13)00265-5
439 An In Vivo RNAi Screening Approach to Identify Host Determinants of Virus Replication.
http://www.cell.com/cell-host-microbe/abstract/S1931-3128(13)00289-8
438 SIV-Induced Instability of the Chimpanzee Gut Microbiome.
http://www.cell.com/cell-host-microbe/abstract/S1931-3128(13)00287-4
437 Alterations in the Gut Microbiota Associated with HIV-1 Infection.
http://www.cell.com/cell-host-microbe/abstract/S1931-3128(13)00288-6
436 Enteroviruses Harness the Cellular Endocytic Machinery to Remodel the Host Cell Cholesterol Landscape for Effective Viral Replication.
http://www.cell.com/cell-host-microbe/abstract/S1931-3128(13)00266-7
435 Colonizing enteric bacteria are shown to inhibit the antimicrobial process of host cell apoptosis through the action of NleB1, a type III secretion system effector with N-acetylglucosamine transferase activity, which can bind and modify eukaryotic death-domain-containing proteins.
http://www.nature.com/nature/journal/v501/n7466/full/nature12524.html
434 The entire hepatitis C virus life cycle can be recapitulated in an inbred mouse model, allowing preclinical assessment of antiviral therapeutics and vaccines.
http://www.nature.com/nature/journal/v501/n7466/full/nature12427.html
433 Reprogramming microbes to be a pathogen-seeking killer.
http://pubs.acs.org/doi/abs/10.1021/sb400077j
432 Development of Norwalk Virus-Specific Monoclonal Antibodies with Therapeutic Potential for the Treatment of Norwalk Virus Gastroenteritis.
http://jvi.asm.org/content/87/17/9547
|
